close

Strike action from Thursday 27 June to Tuesday 2 July 2024

Junior doctors at The Christie will strike from 7am on Thursday 27 June until 7am on Tuesday 2 July 2024.

We are proactively contacting patients with appointments that may be affected. If you have an appointment on any of these dates, please continue to come to The Christie and our other centres as planned, unless we contact you to tell you otherwise. Please do not call to check if your appointment is still going ahead.

Skip to Content

Other publications - Elizabeth (Beth) Phillips

Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma
TM Illidge, EH Phillips, N Counsell, R Pettengell, PMW Johnson et al
Blood Advances 2020; 4 (1): 203-206

PET score has greater prognostic significance than pre-treatment risk stratification in early-stage Hodgkin lymphoma in the UK NCRI RAPID study (joint first author)
SF Barrington, EH Phillips, N Counsell, B Hancock, R Pettengell, P Johnson, W Townsend, D Culligan, B Popova, L Clifton-Hadley, A McMillan, T Illidge, MJ O’Doherty, P Hoskin, J Radford
Journal of Clinical Oncology 2019,37:1732-1741

The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T-cells.
W Townsend, M Pasikowska, D Yallop, EH Phillips, PEM Patten, JR Salisbury, R Marcus, A Pepper, S Devereux
Haematologica 2019, DOI: 10.3324/haematol.2019.220160

Guidelines for the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma (British Society for Haematology Guideline)
CP Fox, EH Phillips, J Smith, K Linton, E Gallop-Evans, C Hemmaway, DP AuerC Fuller, P McKay, K Cwynarski.
British Journal of Haematology 2019;184(3):348-363

Toxicity and efficacy of alemtuzumab combined with CHOP for aggressive T-cell lymphoma: a phase 1 dose-escalation trial
EH Phillips, S Devereux, J Radford, N Mir, T Adedayo, L Clifton-Hadley, R Johnson
Leukemia and Lymphoma 2019, DOI: 10.1080/10428194.2019.1576870

High Dose Chemotherapy and Autologous Stem Cell Transplantation in Enteropathy-Associated and other Aggressive T-Cell Lymphomas
EH Phillips, MM Lannon, A Lopes, H Chadwick, G Jones, M Sieniawski, A Davies, L Clifton-Hadley, P Smith, A Lawrie, N Chadwick, AL Lennard
Bone Marrow Transplantation 2019;54(3):465-468

Obinutuzumab for frontline treatment of follicular lymphoma
R Marcus, A Davies, K Ando, W Klapper, S Opat, C Owen, E Phillips, R Sangha, R Schlag, JF Seymour, W Townsend, M Trneny, M Wenger, G Fingerle-Rowson, K Rufibach, T Moore, M Herold, W Hiddemann
New England Journal of Medicine 2017; 377:1331-1344

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration.
M Pasikowska, E Walsby, B Apollonio, K Cuthill, EH Phillips, E Coulter, MS Longhi, Y Ma, D Yallop, LD Barber, P Patten, C Fegan, AG Ramsay, C Pepper, S Devereux, AG Buggins
Blood 2016; 128(4):563-73

Striving to cure adult T-cell leukaemia/lymphoma: a role for allogeneic stem cell transplantation?
EH Phillips, A Hodson, O Hermine, A Bazarbachi, K Cwynarski
Bone Marrow Transplantation 2017;51(12):1549-1555

The Role of ADAMTS-13 Activity and Complement Mutational Analysis in Differentiating Thrombotic Microangiopathies
EH Phillips, JP Westwood, V Brocklebank, EK Wong, JO Tellez, KJ Marchbank, S McGuckin, DP Gale, J Connolly, TH Goodship, D Kavanagh, M Scully
Journal of Thrombosis and Haemostasis 2016; 14 (1): 175-85

Primary CNS Lymphoma
EH Phillips, CP Fox, K Cwynarski.
Current Hematologic Malignancy Reports 2014; 9 (3): 243-53

Last updated: January 2023